Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gene test may spare some breast cancer patients from chemo

NCT ID NCT03843346

First seen Apr 30, 2026 · Last updated Apr 30, 2026

Summary

This study looked at how a special tumor test, called the 21 gene Recurrence Score (OncotypeDx), affects whether doctors recommend chemotherapy for women with a common type of early-stage breast cancer. Researchers tracked 87 patients in Ireland to see if the test results changed treatment plans. The goal was to understand if the test helps avoid unnecessary chemotherapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Beaumont Hospital

    Dublin, Dublin 9, Ireland

  • Bon Secour Cork

    Cork, Ireland

  • Cork University Hospital

    Cork, Ireland

  • Letterkenny University Hospital

    Letterkenny, Co. Donegal, Ireland

  • Mater Misericordiae University Hospital & Mater Private Hospital

    Dublin, Dublin 7, Ireland

  • St James' Hospital

    Dublin, Ireland

  • St Vincent's University Hospital

    Dublin, Dublin 4, Ireland

  • University Hospital Galway

    Galway, Ireland

  • University Hospital Limerick

    Limerick, V94 F858, Ireland

  • University Hospital Waterford

    Waterford, Ireland

Conditions

Explore the condition pages connected to this study.